Pediatrix Medical (MD) Short term Debt (2009 - 2026)

Pediatrix Medical (MD) has 14 years of Short term Debt data on file, last reported at $192.4 million in Q1 2026.

• Short term Debt for Q1 2026 came in at $192.4 million, up 769.58% year-over-year; the trailing twelve-month figure through Mar 2026 was $192.4 million (up 769.58% YoY), and the FY2025 annual result was $26.8 million, up 30.47% from the prior year.
• Short term Debt grew to $192.4 million in Q1 2026 per MD's latest filing, from $26.8 million in the prior quarter.
• Over five years, Short term Debt peaked at $192.4 million in Q1 2026 and troughed at $14.9 million in Q4 2022.
• A 5-year average of $29.3 million and a median of $17.1 million in 2024 frame the typical range for Short term Debt.
• The sharpest annual moves came in 2023 and 2026: Short term Debt declined 0.02% in 2023, then surged 769.58% in 2026.
• A 5-year view of Short term Debt shows it stood at $14.9 million in 2022, then rose by 0.1% to $14.9 million in 2023, then jumped by 37.77% to $20.5 million in 2024, then soared by 30.47% to $26.8 million in 2025, then jumped by 617.83% to $192.4 million in 2026.
• Business Quant data shows MD's Short term Debt at $192.4 million in Q1 2026, $26.8 million in Q4 2025, and $25.3 million in Q3 2025.